Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Wood

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
British Journal of Cancer|July 15, 2015
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancerNathalie Quenel-Tueux, Marc Debled, Justine Rudewicz, et al.
Transplantation and Cellular Therapy|August 14, 2023
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome PatientsDaniele Avenoso, Varun Mehra, Liron Barnea Slonim, et al.
Cell Stem Cell|June 2, 2023
Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophilsHector Huerga Encabo, Iker Valle Aramburu, Manuel Garcia-Albornoz, et al.
Journal of the National Cancer Institute|April 7, 2021
EGFR Amplification in Metastatic Colorectal CancerGiovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
British Journal of Cancer|July 15, 2015
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancerNathalie Quenel-Tueux, Marc Debled, Justine Rudewicz, et al.
Transplantation and Cellular Therapy|August 14, 2023
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome PatientsDaniele Avenoso, Varun Mehra, Liron Barnea Slonim, et al.
Cell Stem Cell|June 2, 2023
Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophilsHector Huerga Encabo, Iker Valle Aramburu, Manuel Garcia-Albornoz, et al.
Journal of the National Cancer Institute|April 7, 2021
EGFR Amplification in Metastatic Colorectal CancerGiovanni Randon, Rona Yaeger, Jaclyn F Hechtman, et al.
Pageof 3